Close
28/05/2015
Synchrotron light applications for the pharmaceutical industry
More than forty people from the pharmaceutical sector attended the workshop organised by the ALBA Synchrotron on May 7.

Researchers from the MSPD, CLAESS, XALOC, NCD and MISTRAL ALBA beam lines have shown the available state-of-the-art techniques and the advantages that they offer in this field: fast data acquisition and shorter experiments, cost savings and, in the case of X-ray microscopy, suppression of ethical conflicts because this technique can be a previous step before clinical essays with animals and persons.

The companies Enantia and Almirall, which have already collaborated with the ALBA Synchrotron, have commented their own experiences at the facility. Enantia, specialised in research solutions for other companies, has detailed different examples. For Almirall, the analysis of polymorphic compounds – performed at ALBA – has increased its quality control, verifying and quantifying purity grades.

News based on the press release issued by the ALBA synchrotron.

Image: ALBA synchrotron. Structure of a herpesvirus nuclease-antiviral complex. Data collected at the Xaloc beam line (Bongarzone, S., Nadal, M. & Coll, M., IBMB)

More news

31/01/2015 Iranian entrepreneurs at the ALBA synchrotron 22/01/2015 What is a synchrotron and how it works? 15/01/2015 AFM2015 at ICMAB: Nanoscale Characterization of Functional Materials 08/01/2015 Ice under investigation: ICN2 and ICMAB sign an agreement with SnowWorld 23/12/2014 Kymos Pharma Services in the PTV 18/12/2014 Barcelona is one of the 20 best cities for students
35 36 37 38 39 40 41 42 43 44 45